Find the top consultant
for your next big project.

As the leader of CRA's global Life Sciences practice, Dr. Bell’s business consulting work focuses on the economics of competitive strategy. He works with clients to build sustainable competitive advantages for products, franchises, and brands. These projects have focused on opportunity assessment, product launch, pricing and positioning, marketing strategy, channel management, and resource optimization issues. Dr. Bell has led and consulted projects concerning licensing and valuation, game theory and competitive strategy, capital budgeting and real options, and cost-benefit analyses. Immuno-oncology, rare disease therapeutics, cell and gene therapies, and the relationship among pharmaceuticals, diagnostics, and medtech areas of focus. As an expert witness, Dr. Bell frequently testifies on damages in intellectual property, finance, and antitrust litigation in courts and arbitration proceedings in North America, Europe, Asia, and Australia. Recent expert witness engagements have included assessments of commercially reasonable efforts regarding collaborations and asset purchases in the life sciences industries, including the use of contingent value rights. Dr. Bell brings his experience as a Chartered Professional Accountant in Canada and his expertise as a Master of Business Administration and Ph.D. in Business Economics from Harvard University, where he specialized in strategy and international business, to bear on consulting projects.

Corporate strategy issues in Life Sciences, including pharmaceuticals, biotech, devices, and diagnostics, Expert witness services in competition, damages, transfer pricing related to life sciences, intellectual property, and international arbitration.

CRA combines in-depth industry knowledge and cutting-edge analytics to evaluate issues being litigated and debated in the healthcare sector. Their industry knowledge enables them to explain, for example, the nuances of provider reimbursement or the patient incentives created by high deductible health insurance plans, and their economic, statistical, accounting, investigative, and finance skills—as well as their familiarity with key healthcare datasets—equips CRA to provide rigorous, defensible analyses tailored to the specific facts of a litigation or regulatory dispute. CRA experts have broad and deep experience in the healthcare sector including hospitals, physician practices, health insurance and health benefit plans, ACOs, PBMs, wholesalers, pharmacies, pharmaceuticals and biologicals, medical devices, clinical laboratories, dialysis facilities, ambulance transport, nursing homes, and home healthcare. CRA’s Focus Areas Healthcare Antitrust Litigation Healthcare Class Certification Healthcare Damages & Quantum Healthcare Fraud & False Claims Healthcare M&A Healthcare Reimbursement Related capabilities Analytics Antitrust & Competition Forensic Accounting Investigations & Compliance Life Sciences Management Consulting Mergers & Acquisitions Life Sciences We bring clarity to complex challenges. For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements. Our focus areas Corporate, Portfolio, & Brand Strategy Pricing & Market Access Policy Litigation Related capabilities Analytics Antitrust & Competition Forensic Accounting Damages & Quantum Cybersecurity, Information Security, & Privacy Intellectual Property